Tufts Clinical and Translational Research Institute

塔夫茨临床与转化研究所

• 批准号: 8720917
• 负责人: Harry P. Selker
• 金额: $ 41.85万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-26 至 2018-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8720917
• 关键词: Address; Clinical; Clinical Research; Clinical Sciences; Commit; Communities; Complement; Development; Discipline; Education; Health; Health Policy; Home environment; Hospitals; Institutes; Institution; Instruction; Leadership; Methods; Occupational activity of managing finances; Office of Administrative Management; Personnel Management; Policies; Principal Investigator; Public Health; Research; Research Institute; Resources; Schools; Science; Services; Structure; System; Training and Education; Translational Research; Translations; Universities; base; bench to bedside; care delivery; clinical practice; industry partner; innovation; meetings; novel; programs

Program Director/Principal Investigator (Last, First. Middle): Selker, Harry P. PROJECT SUMMARY (See Instnjctions): Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical arid translational research (CTR) to meet the promise of biomedical science, not only bench to bedside ( T l " ) translation, crucial to having health impact, translation into effective clinical practice ("T2"), care delivery and public health ("T3"), and health policy ('T4"). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic Institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectnjm. Described in our application's four sections are four alms that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutions;3) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and targeted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, services and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4:Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instructions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench to bedside (¿T1") translation and crucially for having health impact, translation into effective cllnicalpractlce ("T2"), care delivery and public health ("TS"), and health policy ('74").

项目负责人/主要研究者（最后，第一。作者：Selker，Harry P. 项目总结（见说明）： 申请我们的第二个CTSA，塔夫茨临床和转化科学研究所（CTSl）仍然热切 致力于全方位的临床和转化研究（CTR），以满足以下承诺： 生物医学科学，不仅仅是从工作台到床边（T l“）的翻译，对健康影响至关重要，翻译 有效的临床实践（“T2”）、护理提供和公共卫生（“T3”）以及卫生政策（“T4”）。2008年 我们在先前的CTR资源、服务和教育计划的基础上开始了塔夫茨CTSl，我们故意 选定的合作伙伴将利用和补充彼此的特殊资产。我们的38个战略- 选定的合作伙伴包括12个塔夫茨大学学校/研究中心，10个塔夫茨医院，3个学术 机构（布兰迪斯大学、东北大学、兰德公司），8个社区机构 组织，和五个行业合作伙伴，一个优秀的和协同的资源，机会， 在T1-T4层的教育。在我们的应用程序的四个部分中描述了四个基于 该平台：目标1：通过以下方式全面加强塔夫茨CTSl：1）组织和领导其合作伙伴， 致力于共同技术合作伙伴这一共同家园; 2）扩大所有合作伙伴有效获得全方位的 高质量的资源，以促进跨学科和机构的合作CTR;3） 通过地方和国家的领导和新方法的开发来推进CTR领域;4） 在整个T1-4教育系统提供创新和有针对性的教育和培训。（第一节）AIM 2： 运营和实施CTR之家及其基础设施、服务和计划，包括其 中央办公室人事、行政和财务管理系统、委员会和其他 必要的结构。目标3：维持和发展创新资源、服务和政策， 支持和促进合作，跨学科，全方位的转化研究。（第三节） 4：通过T1-T4范围内的教育和培训，发展和扩大CTR劳动力， 特别关注解决从实验室到床边以及从床边到广泛应用之间的转换差距 对健康的影响（第四节） 相关性（见说明）： 塔夫茨临床和转化科学研究所使用的临床和转化的整个频谱 研究（CTR），以帮助满足生物医学科学的承诺和公众的需求。这包括板凳 到床边（“T1”）的转化，并且对于产生健康影响至关重要，转化为有效的临床实践 （“T2”）、护理提供和公共卫生（“TS”）以及卫生政策（“74”）。